The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
21.53
+0.73 (3.51%)
Nov 22, 2024, 4:00 PM EST - Market closed
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 5,749 | 6,027 | 6,794 | 6,345 | 4,969 | 5,526 | Upgrade
|
Revenue Growth (YoY) | -4.25% | -11.29% | 7.08% | 27.69% | -10.08% | -16.75% | Upgrade
|
Cost of Revenue | 4,616 | 4,721 | 5,178 | 4,964 | 3,902 | 4,463 | Upgrade
|
Gross Profit | 1,133 | 1,306 | 1,616 | 1,381 | 1,067 | 1,063 | Upgrade
|
Selling, General & Admin | 536 | 526 | 705 | 583 | 526 | 536 | Upgrade
|
Research & Development | 109 | 108 | 118 | 107 | 93 | 80 | Upgrade
|
Other Operating Expenses | -1 | -1 | - | - | 1 | - | Upgrade
|
Operating Expenses | 644 | 633 | 823 | 690 | 620 | 616 | Upgrade
|
Operating Income | 489 | 673 | 793 | 691 | 447 | 447 | Upgrade
|
Interest Expense | -260 | -208 | -163 | -185 | -210 | -208 | Upgrade
|
Earnings From Equity Investments | 41 | 45 | 55 | 43 | 23 | 29 | Upgrade
|
Currency Exchange Gain (Loss) | -23 | -38 | -15 | 3 | -26 | -2 | Upgrade
|
Other Non Operating Income (Expenses) | 14 | 19 | 59 | 36 | 38 | 67 | Upgrade
|
EBT Excluding Unusual Items | 261 | 491 | 729 | 588 | 272 | 333 | Upgrade
|
Merger & Restructuring Charges | -65 | -154 | -16 | -6 | -32 | -87 | Upgrade
|
Impairment of Goodwill | -56 | - | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 7 | 110 | 21 | 115 | 8 | 10 | Upgrade
|
Asset Writedown | - | - | - | - | -10 | - | Upgrade
|
Legal Settlements | -118 | -764 | - | - | -37 | - | Upgrade
|
Other Unusual Items | - | -1 | 7 | -21 | -22 | -380 | Upgrade
|
Pretax Income | 49 | -318 | 741 | 676 | 179 | -124 | Upgrade
|
Income Tax Expense | -29 | -81 | 163 | 68 | -40 | -72 | Upgrade
|
Earnings From Continuing Operations | 78 | -237 | 578 | 608 | 219 | -52 | Upgrade
|
Minority Interest in Earnings | -2 | -1 | - | - | - | - | Upgrade
|
Net Income | 76 | -238 | 578 | 608 | 219 | -52 | Upgrade
|
Net Income to Common | 76 | -238 | 578 | 608 | 219 | -52 | Upgrade
|
Net Income Growth | - | - | -4.93% | 177.63% | - | - | Upgrade
|
Shares Outstanding (Basic) | 149 | 149 | 155 | 165 | 165 | 165 | Upgrade
|
Shares Outstanding (Diluted) | 150 | 149 | 158 | 169 | 166 | 165 | Upgrade
|
Shares Change (YoY) | 0.41% | -5.93% | -6.16% | 1.41% | 0.93% | -9.73% | Upgrade
|
EPS (Basic) | 0.51 | -1.60 | 3.72 | 3.69 | 1.33 | -0.32 | Upgrade
|
EPS (Diluted) | 0.50 | -1.60 | 3.65 | 3.60 | 1.32 | -0.32 | Upgrade
|
EPS Growth | - | - | 1.39% | 172.73% | - | - | Upgrade
|
Free Cash Flow | -675 | 186 | 448 | 537 | 540 | 169 | Upgrade
|
Free Cash Flow Per Share | -4.51 | 1.25 | 2.83 | 3.18 | 3.25 | 1.03 | Upgrade
|
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Upgrade
|
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 19.05% | Upgrade
|
Gross Margin | 19.71% | 21.67% | 23.79% | 21.77% | 21.47% | 19.24% | Upgrade
|
Operating Margin | 8.51% | 11.17% | 11.67% | 10.89% | 9.00% | 8.09% | Upgrade
|
Profit Margin | 1.32% | -3.95% | 8.51% | 9.58% | 4.41% | -0.94% | Upgrade
|
Free Cash Flow Margin | -11.74% | 3.09% | 6.59% | 8.46% | 10.87% | 3.06% | Upgrade
|
EBITDA | 786 | 980 | 1,084 | 1,008 | 767 | 715 | Upgrade
|
EBITDA Margin | 13.67% | 16.26% | 15.96% | 15.89% | 15.44% | 12.94% | Upgrade
|
D&A For EBITDA | 297 | 307 | 291 | 317 | 320 | 268 | Upgrade
|
EBIT | 489 | 673 | 793 | 691 | 447 | 447 | Upgrade
|
EBIT Margin | 8.51% | 11.17% | 11.67% | 10.89% | 9.00% | 8.09% | Upgrade
|
Effective Tax Rate | - | - | 22.00% | 10.06% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.